For the millions of older adults navigating a daily regimen of five, seven, or even ten medications, the risk of harm quietly compounds with each added prescription. Researchers at Mass General Brigham have asked whether artificial intelligence might help untangle this pharmaceutical complexity, testing ChatGPT's capacity to assist in deprescribing decisions for elderly patients. The findings, published in the Journal of Medical Systems, suggest the technology holds genuine promise but carries inconsistencies and blind spots that remind us how much distance remains between a capable tool and a
News-Medical.net
· Apr 18, 2024
· health
· 2 min read
High
Sourcing: Verified
ChatGPT Shows Promise in Managing Polypharmacy for Older Adults
Polypharmacy in older adults increases risk of adverse drug interactions and medication-related harm, affecting millions of seniors.
◉
Technology
8621 related articles
Google Pixel 11 Pro Fold launches with Tensor G6, Gemini AI, and new O…
Business Today · 100% match
Honor's Robot Phone and Google Pixel 11 Lead Week's Tech Innovation Ra…
Google News · 99% match
Tech Giants Embrace Nuclear Power to Meet Surging AI Energy Demands
CNBC · 99% match
AI's Power Hunger Derails Big Tech's Climate Pledges
Fortune · 99% match
Google to Retire Assistant on Phones, Watches by September 2026
Bangkok Post · 99% match
Related Coverage
BBC News · Aug 22
Papers lead on Harry's legal costs ruling, Mandelson probe collapse risk
Saturday's UK papers lead on Prince Harry's privacy case costs ruling, Lord Mandelson's stalled investigation, and MPs' …
GSMArena.com · Aug 22 vivo V70 Lite 4G launches with 8,100mAh battery and IP69 durabilityvivo introduces V70 Lite 4G with Unisoc T7300 chipset, 8,100mAh battery, 6.83-inch AMOLED display, and IP69 water resist…
CNN · Aug 22 AI Decimates China's Microdrama Industry, Displacing Thousands of ActorsAI video generation tools have rapidly displaced live-action microdrama production in China, with 95% of releases now AI…
The Times of India · Aug 22 IISc Researcher Turns Personal Tragedy Into AI-Powered Breast Cancer Detection ToolDr. Geetha Manjunath, an IISc gold medallist and AI researcher, founded NIRAMAI to detect breast cancer early using ther…
Bias & Framing
No detailed analysis data available for this lens. Try re-running lenses from the admin panel.
Geopolitical Impact
🌎
ChatGPT demonstrates potential for managing polypharmacy in elderly patients but exhibits inconsistencies and biases requiring refinement before clinical use.
Escalation Risk
low
Confidence
LOW
Economic Lens
📈
ChatGPT shows potential for managing polypharmacy in elderly patients but requires refinement due to inconsistencies and biases before clinical implementation.
Market Signal
mixed
Confidence
MED
Healthcare/Pharmaceuticals
Artificial Intelligence/Software
Medical Devices
Primary Care Services
Elderly Care/Geriatrics
Elderly patients could benefit from improved medication management and reduced adverse drug interactions, but current AI limitations pose safety risks. Healthcare costs may decrease through optimized deprescribing, though implementation delays due to validation needs may slow consumer benefits.
Regulators (FDA, CMS) will likely require rigorous validation protocols before AI-assisted deprescribing tools can be deployed clinically. Healthcare systems may need updated liability frameworks and physician oversight requirements. Potential for new reimbursement models for AI-assisted medication reviews.